Cargando…
Per‐Protocol Versus Intention‐to‐Treat in Clinical Trials: The Example of GLOBAL‐LEADERS Trial
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238553/ https://www.ncbi.nlm.nih.gov/pubmed/35574954 http://dx.doi.org/10.1161/JAHA.122.025561 |
| _version_ | 1784737080964808704 |
|---|---|
| author | Santos‐Gallego, Carlos G. Requena‐Ibanez, Juan Antonio Badimon, Juan |
| author_facet | Santos‐Gallego, Carlos G. Requena‐Ibanez, Juan Antonio Badimon, Juan |
| author_sort | Santos‐Gallego, Carlos G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9238553 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92385532022-06-30 Per‐Protocol Versus Intention‐to‐Treat in Clinical Trials: The Example of GLOBAL‐LEADERS Trial Santos‐Gallego, Carlos G. Requena‐Ibanez, Juan Antonio Badimon, Juan J Am Heart Assoc Original Research John Wiley and Sons Inc. 2022-05-16 /pmc/articles/PMC9238553/ /pubmed/35574954 http://dx.doi.org/10.1161/JAHA.122.025561 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Original Research Santos‐Gallego, Carlos G. Requena‐Ibanez, Juan Antonio Badimon, Juan Per‐Protocol Versus Intention‐to‐Treat in Clinical Trials: The Example of GLOBAL‐LEADERS Trial |
| title | Per‐Protocol Versus Intention‐to‐Treat in Clinical Trials: The Example of GLOBAL‐LEADERS Trial |
| title_full | Per‐Protocol Versus Intention‐to‐Treat in Clinical Trials: The Example of GLOBAL‐LEADERS Trial |
| title_fullStr | Per‐Protocol Versus Intention‐to‐Treat in Clinical Trials: The Example of GLOBAL‐LEADERS Trial |
| title_full_unstemmed | Per‐Protocol Versus Intention‐to‐Treat in Clinical Trials: The Example of GLOBAL‐LEADERS Trial |
| title_short | Per‐Protocol Versus Intention‐to‐Treat in Clinical Trials: The Example of GLOBAL‐LEADERS Trial |
| title_sort | per‐protocol versus intention‐to‐treat in clinical trials: the example of global‐leaders trial |
| topic | Original Research |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238553/ https://www.ncbi.nlm.nih.gov/pubmed/35574954 http://dx.doi.org/10.1161/JAHA.122.025561 |
| work_keys_str_mv | AT santosgallegocarlosg perprotocolversusintentiontotreatinclinicaltrialstheexampleofgloballeaderstrial AT requenaibanezjuanantonio perprotocolversusintentiontotreatinclinicaltrialstheexampleofgloballeaderstrial AT badimonjuan perprotocolversusintentiontotreatinclinicaltrialstheexampleofgloballeaderstrial |